Lomustine API (CAS: 13010-47-4) is a high-potent, lipid-soluble alkylating agent used as an antineoplastic agent in oral capsule formulations to treat brain tumors and Hodgkin’s lymphoma. It works by interfering with DNA/RNA function and carbamoylating proteins.